Autozhel' v kontrole biokhimicheskikh markerovaktivnosti akromegalii: predstavlenieklinicheskogo sluchaya
| Autor: | Dzeranova L K, Pigarova E A, Dalantaeva N S, Rozhinskaya L Ya, Giniyatullina E N |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2010 |
| Předmět: |
medicine.medical_specialty
Pediatrics Pituitary gland Physiology Endocrinology Diabetes and Metabolism Disease QD415-436 Lanreotide Biochemistry chemistry.chemical_compound Endocrinology somatulin autogel Quality of life Acromegaly Internal Medicine medicine QP1-981 Patient treatment Surgical treatment Excess growth hormone Nutrition and Dietetics business.industry Public Health Environmental and Occupational Health medicine.disease Surgery medicine.anatomical_structure chemistry acromegaly lanreotide business somatostatin analog |
| Zdroj: | Ожирение и метаболизм, Vol 7, Iss 4, Pp 44-47 (2010) |
| ISSN: | 2306-5524 2071-8713 |
| Popis: | Acromegaly is a severe neuroendocrine disease that develops when the pituitary gland produces excess growth hormone (GH). Acromegaly is not only a cosmetic problem. Hypersecretion of GH leads to variety complications, decreased quality of life, shortening the expected lifespan due to development of severe cardiovascular complications. Timely diagnosis and adequate treatment can reduce mortality by 2-5 times and medical therapy deservedly plays an important role in treatment of patients with acromegaly when radical surgical treatment cannot be performed. We present a first Russian experience of acromegaly patient treatment with new preparation - Somatulin Autogel, with analysis of its favorable effects on clinical and metabolic manifestations of the disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|